Free to browse, no account needed
Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.
Drugs A–Z › Diclofenac
Approved
FDA, Nov 1993
1
Registered trials
What is Diclofenac?
Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX-1 and COX-2), blocking prostaglandin synthesis.
Summary written with AI from the sources listed at the end of this page.
At a glance
Also known as Cataflam, Diclofenac Potassium, Zipsor, ZORVOLEX Drug type Small molecule
Targets
cyclooxygenase-1 (PTGS1), cyclooxygenase-2 (PTGS2)
Mechanism Inhibitor of cyclooxygenase-1 (PTGS1) and cyclooxygenase-2 (PTGS2) Pathways prostaglandin synthesis, arachidonic acid metabolism Therapy area Musculoskeletal Developer
Novartis
In trials of TEVA FDA status
Approved as Cataflam, Diclofenac Potassium, Zipsor (November 24, 1993), NDA020142 · FDA label
✅ FDA-approved uses
Mild to moderate acute pain (Zipsor)
Mild to moderate acute pain (Diclofenac Potassium)
From the indications section of the FDA label (version of Sep 3, 2025). Read the full label for the exact wording, limitations and safety information.
🧪 Clinical trials
Trial Phase Condition Status Sponsor
NCT03949673
Phase 2
Osteoarthritis, Knee
Terminated
TEVA
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Conditions studied
Osteoarthritis, Hip Osteoarthritis, Knee
Other drugs acting on PTGS1 / PTGS2
Sources
Updated Oct 3, 2026.
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z